Life Science Pharmaceuticals (LSP) and its spin-out, Extended Delivery Pharmaceuticals (EDP), are dedicated to developing innovative therapeutics for the treatment of cancer, diabetes, and other serious illnesses. With a diverse portfolio of product candidates in pre-clinical and clinical development, LSP maintains strong partnerships with prestigious academic institutions and international organizations, ensuring the advancement of cutting-edge discoveries in the field.
Having established licensing relationships with renowned institutions such as The Ludwig Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, and The Massachusetts Institute of Technology, LSP has also collaborated successfully with international pharmaceutical companies, including a notable collaboration and licensing agreement with AbbVie. With a focus on groundbreaking research and development, LSP is committed to making significant contributions to the field of healthcare.
Generated from the website